Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 85,016 shares at $1.64 ($137K) on 2022-11-01, disclosed to the SEC on 2022-11-03.
Scheduled sale ($137k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.60 | 56,264 | $90K | 65.6% |
| 2 | $1.64 | 28,752 | $47K | 34.4% |
| Total | $1.61 avg | 85,016 | $137K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |